Short answer
Compass Therapeutics, Inc. (CMPX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Filing contains only the signature page and Exhibit 101 reference.
Compass Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only the signature page and Exhibit 101 reference
- No earnings figures, reporting-period results, or management commentary available in the provided text
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Compass Therapeutics, Inc. 8-K filings
Get the next CMPX 8-K as it lands
Follow CMPX for push alerts, or ask the research agent what this filing means.